Arca
Skip to content
Tools
Tools

Allergies respitatory

Drug research and approvals for allergies respitatory: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 0 studies of allergies respitatory are recruiting on ClinicalTrials.gov, and Health Canada has authorized 12 drug trials for it since 2013.

  • Recruiting worldwide: 0
  • Trials authorized in Canada: 12
  • FDA orphan approvals: 0
  • EU medicines: 0

Trials authorized in Canada

The 10 newest of 12; search them all in Canada trials
Jul 31, 2015A single-centre, randomized, double blind, placebo-controlled, parallel group study to investigate the relative efficacy and safety of immunotherapy with…Sublivac fix phleum pratenseHal Allergy BVOngoing
Jul 3, 2015A double-blind, randomised, placebo-controlled, escalating, multiple dose study in birch-allergic subjects to assess the asfety, tolerability and…Birch-spireCircassia PharmaceuticalsOngoing
Dec 10, 2014A pilot study to compare responses to cat allergen exposure using the environmental exposure chamber (EEC) and nasal allergen challenge (NAC)Cat danderNational Institute of HealthClosed
Nov 13, 2014The effect of peptide immunotherapy on frequency, memory phenotype, chemokine receptor expression and markers of regulatory t cell function allergan-specific t…Cat-padNational Institute of HealthClosed
Mar 28, 2014A multi-centre, double-blind, randomised, placebo-controlled parallel-group study to assess the safety and tolerability of grass-spire in subjects with asthma…Grass-spire (toleromune grass)Circassia PharmaceuticalsOngoing
Nov 22, 2013Inhaled allergen challengeAllergen extract for inhalation (cat hair)McMaster UniversityPending
Nov 22, 2013Segmental allergen challengeAllergen extracts for inhalation (cat pelt), Allergen extracts for inhalation…McMaster UniversityPending
Nov 15, 2013A single group study evaluating reproducibility of rhinitis symptoms induced by allergen exposure in the red maple trials allergen challenge theatre (ACT) in…Greer timothy grass pollenRed Maple Trials IncOngoing
Sep 24, 2013"an optional investigation of biomarkers of efficacy in TH002 clinical study subjects."Toleromune house dust miteCircassia PharmaceuticalsPending
Sep 19, 2013"a mutli-centre, double-blind, randomised, placebo-controlled parallel-group study to assess the tolerability of tolermune house dust mite in subjects with…Tolermune house dust miteCircassia PharmaceuticalsPending

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.